These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8150754)

  • 1. Pharmacokinetics of cefepime in patients with the sepsis syndrome.
    Kieft H; Hoepelman AI; Knupp CA; van Dijk A; Branger JM; Struyvenberg A; Verhoef J
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():117-22. PubMed ID: 8150754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cefepime in patients with thermal burn injury.
    Bonapace CR; White RL; Friedrich LV; Norcross ED; Bosso JA
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2848-54. PubMed ID: 10582870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of cefepime: a review.
    Van der Auwera P; Santella PJ
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():103-15. PubMed ID: 8150753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects.
    Barbhaiya RH; Forgue ST; Gleason CR; Knupp CA; Pittman KA; Weidler DJ; Movahhed H; Tenney J; Martin RR
    Antimicrob Agents Chemother; 1992 Mar; 36(3):552-7. PubMed ID: 1622165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of age and gender on pharmacokinetics of cefepime.
    Barbhaiya RH; Knupp CA; Pittman KA
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1181-5. PubMed ID: 1416818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective monitoring of cefepime in intensive care unit adult patients.
    Chapuis TM; Giannoni E; Majcherczyk PA; Chioléro R; Schaller MD; Berger MM; Bolay S; Décosterd LA; Bugnon D; Moreillon P
    Crit Care; 2010; 14(2):R51. PubMed ID: 20359352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics, safety, and tolerance of cefepime administered as an intravenous bolus or as a rapid infusion.
    Garrelts JC; Wagner DJ
    Ann Pharmacother; 1999 Dec; 33(12):1258-61. PubMed ID: 10630824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-proportional pharmacokinetics of cefepime in rats.
    Brindley CJ; Brodie RR; Cook SC; Oldfield PR; Chasseaud LF; Barbhaiya RH
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():9-14. PubMed ID: 1820942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute-phase response alters the disposition kinetics of cefepime following intravenous administration to rabbits.
    Abd El-Aty AM; Goudah A; Mouneir SM; Sunwoo YE; Jang JH; Shin JG; Shim JH; Shimoda M
    Vet Res Commun; 2007 Jan; 31(1):67-75. PubMed ID: 17186405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma, urine and skin pharmacokinetics of cefepime in burns patients.
    Sampol E; Jacquet A; Viggiano M; Bernini V; Manelli JC; Lacarelle B; Durand A
    J Antimicrob Chemother; 2000 Aug; 46(2):315-7. PubMed ID: 10933661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple dose pharmacokinetics, safety, and effects on faecal microflora, of cefepime in healthy volunteers.
    Bächer K; Schaeffer M; Lode H; Nord CE; Borner K; Koeppe P
    J Antimicrob Chemother; 1992 Sep; 30(3):365-75. PubMed ID: 1452502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cefepime in subjects with renal insufficiency.
    Barbhaiya RH; Knupp CA; Forgue ST; Matzke GR; Guay DR; Pittman KA
    Clin Pharmacol Ther; 1990 Sep; 48(3):268-76. PubMed ID: 2401125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cefepime during continuous renal replacement therapy in critically ill patients.
    Malone RS; Fish DN; Abraham E; Teitelbaum I
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3148-55. PubMed ID: 11600370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cefepime in cystic fibrosis patients.
    Huls CE; Prince RA; Seilheimer DK; Bosso JA
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1414-6. PubMed ID: 8363368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of ceftazidime and cefepime in burn patients: the importance of age and creatinine clearance.
    Conil JM; Georges B; Lavit M; Seguin T; Tack I; Samii K; Chabanon G; Houin G; Saivin S
    Int J Clin Pharmacol Ther; 2007 Oct; 45(10):529-38. PubMed ID: 17966838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of intravenously and intramuscularly administered cefepime in infants and children.
    Reed MD; Yamashita TS; Knupp CK; Veazey JM; Blumer JL
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1783-7. PubMed ID: 9257761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic population study to describe cefepime lung concentrations.
    Breilh D; Saux MC; Delaisement C; Fratta A; Ducint D; Velly JF; Couraud L
    Pulm Pharmacol Ther; 2001; 14(2):69-74. PubMed ID: 11273786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefepime versus cefpirome: the importance of creatinine clearance.
    Lipman J; Wallis SC; Boots RJ
    Anesth Analg; 2003 Oct; 97(4):1149-1154. PubMed ID: 14500173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cefepime administered by i.v. and i.m. routes to ewes.
    Ismail M
    J Vet Pharmacol Ther; 2005 Dec; 28(6):499-503. PubMed ID: 16343281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics change of cefepime after Shuanghuanglian injection administration in subjects with the renal damage.
    Chen H; Min J; Li W; Zhao W; Mi S; Wang N; Zhu C
    Drug Chem Toxicol; 2016; 39(2):129-36. PubMed ID: 26108148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.